Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
49 /100
MEDIUM RISK
Score updated Oct 13, 2026

CNSP — CNS Pharmaceuticals, Inc. Dilution Risk Tracker

Track CNSP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CNSP — Get alerts when the score changes →

As of October 13, 2026, CNS Pharmaceuticals, Inc. (CNSP) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. CNS Pharmaceuticals, Inc. has a market capitalization of $7.58M, 1.46M shares outstanding, 10 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CNSP.
🔔 Track CNSP — Get forecast alerts →

Market Data

Market Cap$7.58M
Shares Outstanding1.46M
Float1.45M
Cash$19.98M
Debt$449.9K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore49/100DilutionWatch score record
Shares Outstanding1.46MVerified float table or market cache
Public Float1.45MVerified float table or market cache
Market Cap$7.58MMarket data cache
Cash Runway15.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 3 2, 4 2, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 124.4K shares
#1 Stonepine Capital Management, LLC 48.8K shares
#2 Ikarian Capital, LLC 45.8K shares
#3 DRW Securities, LLC 15.4K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest898
Days to Cover1.0
% of Float0.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2026-03-31
8-K 8K EVENT 2026-05-04
4 INSIDER TRANSACTION 2026-03-04
3 FORM3 2026-03-04
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CNSP Dilution Snapshot

CNS Pharmaceuticals, Inc. (CNSP) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CNSP's DilutionScore is currently 49/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 75/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202649/100MEDIUM53 days
Aug 14 – Aug 21, 202675/100HIGH7 days
Jul 16 – Aug 13, 202666/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CNSP shares outstanding have increased 80.1% from 811.4K (Apr 2026) to 1.46M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 20261.46M1.45M▲ 12.66%
May 02, 2026811.4K716.8K▲ 0.13%
Apr 10, 2026811.4K715.8K▲ 0.12%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CNSP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CNSP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CNSP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CNSP
CNSP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.